Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-3-25
pubmed:abstractText
Preparations rich in growth factors (PRGF) release them plus bioactive proteins at localized sites, with the aim of triggering healing and regenerative processes. The prevailing paradigm suggests that their influence on proliferation, angiogenesis and the extracellular matrix synthesis is minimal. However, variations in their composition and impact on different cell phenotypes have not been examined.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Thy-1, http://linkedlifedata.com/resource/pubmed/chemical/Biological Agents, http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I, http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, Conditioned, http://linkedlifedata.com/resource/pubmed/chemical/Fibrin, http://linkedlifedata.com/resource/pubmed/chemical/HGF protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Hyaluronic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Procollagen-Proline Dioxygenase, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1, http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1365-2184
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
162-70
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19250293-Antigens, Thy-1, pubmed-meshheading:19250293-Biological Agents, pubmed-meshheading:19250293-Blood Coagulation, pubmed-meshheading:19250293-Cell Proliferation, pubmed-meshheading:19250293-Cells, Cultured, pubmed-meshheading:19250293-Collagen Type I, pubmed-meshheading:19250293-Culture Media, Conditioned, pubmed-meshheading:19250293-Fibrin, pubmed-meshheading:19250293-Fibroblasts, pubmed-meshheading:19250293-Hepatocyte Growth Factor, pubmed-meshheading:19250293-Humans, pubmed-meshheading:19250293-Hyaluronic Acid, pubmed-meshheading:19250293-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:19250293-Male, pubmed-meshheading:19250293-Platelet-Rich Plasma, pubmed-meshheading:19250293-Procollagen-Proline Dioxygenase, pubmed-meshheading:19250293-Skin, pubmed-meshheading:19250293-Synovial Membrane, pubmed-meshheading:19250293-Tendons, pubmed-meshheading:19250293-Transforming Growth Factor beta1, pubmed-meshheading:19250293-Vascular Endothelial Growth Factor A
pubmed:year
2009
pubmed:articleTitle
Fibroblastic response to treatment with different preparations rich in growth factors.
pubmed:affiliation
Biotechnology Institute, BTI IMASD, Vitoria-Gasteiz, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't